Mangoceuticals (MGRX) Price to Earnings (2023 - 2026)

Mangoceuticals has disclosed Price to Earnings across 4 years of filings, most recently posting 4.26 for Q2 2026.

• In Q2 2026, Price to Earnings fell 50.39% year-over-year to 4.26; the TTM figure through Jun 2026 stood at 0.42 (up 60.79% YoY), while the FY2025 annual figure was 0.34, up 32.18% from the prior year.
• Price to Earnings came in at 4.26 for Q2 2026 at Mangoceuticals, down from 1.65 in the prior quarter.
• In the past five years, Price to Earnings ranged from a high of 1.65 in Q1 2026 to a low of 13.39 in Q2 2023.
• Average Price to Earnings over 4 years is 3.99, with a median of 3.01 recorded in 2025.
• Year-over-year, Price to Earnings soared 72.34% in 2024 and tumbled 50.39% in 2026.
• Over 4 years, Price to Earnings stood at 1.74 in 2023, then slumped by 41.49% to 2.46 in 2024, then grew by 1.03% to 2.43 in 2025, then slumped by 75.17% to 4.26 in 2026.
• Per Business Quant data, the three most recent Price to Earnings figures were 4.26 in Q2 2026, 1.65 in Q1 2026, and 2.43 in Q4 2025.